TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06406790: CraniSeal Post Approval Study

Sponsor: Pramand LLC · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 224 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$4,063,680

Rescue Site Savings

+$2,682,560

Unlock Full NCT06406790 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06406790 Rescue Dossier →